E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers M > Headlines for MediciNova, Inc. > News item
Published on 10/16/2013 in the Prospect News PIPE Daily.

MediciNova arranges $10 million at-the-market offering of common stock

Macquarie as agent will be paid 7% commission on stock sales

By Devika Patel

Knoxville, Tenn., Oct. 16 - MediciNova, Inc. negotiated a $10 million at-the-market offering of common stock with agent Macquarie Capital (USA) Inc., according to an 8-K filed Wednesday with the Securities and Exchange Commission.

Macquarie will be paid a 7% commission.

MediciNova is a San Diego-based development-stage biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.